Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Letters|May 5, 2012
Breast cancer stem cells: obstacles to therapyMatthew Smalley, Luke Piggott, Richard Clarkson
Breast Cancer Research : BCR|September 15, 2011
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAILLuke Piggott, Nader Omidvar, Salvador Martí Pérez, et al.
Viruses|June 2, 2021
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20James A Davies, Gareth Marlow, Hanni K Uusi-Kerttula, et al.
Molecular Cancer Therapeutics|March 2, 2021
The Discovery of a Novel Antimetastatic Bcl3 InhibitorJitka Soukupová, Cinzia Bordoni, Daniel J Turnham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIPLuke Piggott, Andreia Silva, Timothy Robinson, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib studyGlenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, et al.
Journal for Immunotherapy of Cancer|October 31, 2019
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancerGareth D Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, et al.
Immunology and Cell Biology|March 31, 2017
Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cellsHung-Chang Chen, Noémie Joalland, John S Bridgeman, et al.
Pageof 1